Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ruzurgi Approved for Pediatric Lambert-Eaton Myasthenic Syndrome (LEMS)

drugsJune 03, 2019

Tag: Ruzurgi , LEMS , FDA , potassium , channel

PharmaSources Customer Service